Across TCGA pan-cancer cohorts, APOBR Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated APOBR data layer compared with 25 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in glioblastoma multiforme (GBM), where higher APOBR Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated APOBR expression acts as an unfavorable survival marker.

GBM and LIHC are the cancer types where APOBR Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
GBM	OS	Median	All	0.024	0.416	<.001	6	view →
LIHC	DFS	Median	All	0.096	0.526	.023	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: APOBR tumor-vs-normal RNA expression · all APOBR data types